Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Yakup iriagac"'
Publikováno v:
Bagcilar Medical Bulletin, Vol 7, Iss 2, Pp 130-136 (2022)
Objective:We aimed to investigate the factors affecting the complete response (CR) rate and the effect of treatment response on survival in patients with extensive stage-small cell lung cancer (ES-SCLC) who received a combination of cisplatin and eto
Externí odkaz:
https://doaj.org/article/89fa797805a6474cabc2527eae241fa2
Publikováno v:
Ahi Evran Medical Journal, Vol 6, Iss 1, Pp 71-76 (2022)
Purpose: Small cell lung cancer (SCLC) is a type of lung cancer that is sensitive to chemotherapy but has a poor prognosis. In this study, we aimed to investigate the prognostic significance of the lymphocyte / monocyte ratio and clinical and labora
Externí odkaz:
https://doaj.org/article/b11e99b5be214f4ba2dbcdce858b5f9f
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 9, Iss 3, Pp 255-260 (2021)
Aim:In this study, we investigated the effect of pandemic on the diagnosis-treatment process in breast cancer patients receiving neoadjuvant chemotherapy.Materials and Methods:The clinicopathological characteristics of the total patients who received
Externí odkaz:
https://doaj.org/article/2a2755b144454d3a8f15f151ed92ae06
Autor:
Nebi Serkan Demirci, Eyyup Cavdar, Nuriye Yildirim Ozdemir, Sinemis Yuksel, Yakup Iriagac, Gokmen Umut Erdem, Hatice Odabas, Ilhan Hacibekiroglu, Mustafa Karaagac, Mahmut Ucar, Banu Ozturk, Yakup Bozkaya
Publikováno v:
Medicina, Vol 60, Iss 5, p 818 (2024)
Background and Objectives: In ampullary cancer, 5-year survival rates are 30–50%, even with optimal resection and perioperative systemic therapies. We sought to determine the important clinicopathological features and adjuvant treatments in terms o
Externí odkaz:
https://doaj.org/article/8626dfe6c0064ba792f099060c6a66fb
Publikováno v:
Haseki Tıp Bülteni, Vol 61, Iss 1, Pp 59-68 (2023)
Aim:Complementary therapies are being increasingly preferred in patients receiving anticancer therapy to strengthen the effect of chemotherapy and control cancer-related symptoms. In this study, we investigated the prevalence of complementary therapy
Externí odkaz:
https://doaj.org/article/df101f3f96f84737893f9262ee1a5019
Publikováno v:
Iberoamerican Journal of Medicine, Vol 4, Iss 4, Pp 191-198 (2022)
Introduction: Trastuzumab emtansine (T-DM1) is one of the effective treatment options in human epidermal growth factor receptor 2 (HER2) positive breast cancer patients. In this study, we aimed to find the effect of T-DM1 on survival, its tolerabilit
Externí odkaz:
https://doaj.org/article/4db79f16413e4d81b97ea1819d6debea
Autor:
Erdoğan Selçuk Şeber, Yakup İriagac, Eyyup Çavdar, Kubilay Karaboyun, Okan Avcı, Ahmet Yolcu, Sibel Özkan Gürdal, Meltem Öznur
Publikováno v:
Revista da Associação Médica Brasileira, Volume: 69, Issue: 3, Pages: 434-439, Published: 10 MAR 2023
SUMMARY OBJECTIVE: The aim of this study was to investigate the predictive importance of the previously validated log(ER)*log(PgR)/Ki-67 predictive model in a larger patient population. METHODS: Patients with hormone receptor positive/HER-2 negative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a206941bbfa6870848dbed3df2e0853
https://doi.org/10.1590/1806-9282.20221255
https://doi.org/10.1590/1806-9282.20221255
Autor:
Yakup, IRIAGAC1 yakupiriagac@hotmail.com, Eyyup, CAVDAR1, Kubilay, KARABOYUN1, Okan, AVCI1, Ozkan, ALAN1, Halil, TASKAYNATAN1, Aliye, CELIKKOL1, Sonat Pinar, KARA1, Berna, ERDAL1, Erdogan Selcuk, SEBER1
Publikováno v:
Bratislava Medical Journal / Bratislavské Lekárske Listy. 2022, Vol. 123 Issue 6, p401-407. 7p.
Publikováno v:
Iberoamerican Journal of Medicine. 4:191-198
Introduction: Trastuzumab emtansine (T-DM1) is one of the effective treatment options in human epidermal growth factor receptor 2 (HER2) positive breast cancer patients. In this study, we aimed to find the effect of T-DM1 on survival, its tolerabilit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::157e9acc968f6e2b06d6bdc04a7f39d0
https://doi.org/10.53986/ibjm.2022.0033
https://doi.org/10.53986/ibjm.2022.0033
Publikováno v:
Journal of Geriatric Oncology. 13:821-827
In older patients with cancer, it is very important to choose the appropriate treatment because they are at high risk for chemotherapy toxicity. Our study investigated characteristics of Cancer and Aging Research Group (CARG), Geriatric 8 (G8), and V
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8311577e77737956c64aec529d738b10
https://doi.org/10.1016/j.jgo.2022.03.004
https://doi.org/10.1016/j.jgo.2022.03.004